Press Releases

Press Releasesadmin2023-06-07T15:58:22-04:00

Most recent news

February 27, 2025

Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology

December 14, 2022

Virpax Pharmaceuticals Reports on FDA Pre-IND Response for NobrXiol™ (formerly VRP324)
November 9, 2022

Virpax Pharmaceuticals Reports 2022 Third Quarter Results
August 24, 2022

Dr. Jeffrey Gudin, Chief Medical Officer of Virpax Pharmaceuticals, to Present Poster at World Congress of World Institute of Pain
August 15, 2022

Virpax Pharmaceuticals Reports 2022 Second Quarter Results and Recent Developments
July 5, 2022

Virpax Pursues OTC Medical Device Pathway for AnQlar™
June 27, 2022

Virpax Will Pursue Direct to OTC Pathway for Epoladerm™ for Pain Associated with Osteoarthritis
May 19, 2022

Virpax Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference
May 16, 2022

Virpax Pharmaceuticals Reports 2022 First Quarter Results and Recent Developments
May 5, 2022

Virpax Pharmaceuticals Enters Into CRADA With The U.S. Army Institute of Surgical Research
April 26, 2022

Virpax Successfully Completes Initial Preclinical Studies for VRP324
March 31, 2022

Virpax Pharmaceuticals Reports 2021 Year-End Results
March 22, 2022

Virpax Completes All FDA-Required Pre-Clinical Studies for Epoladerm™
March 15, 2022

Virpax Pharmaceuticals Expands AnQlar™ Development and Commercialization Rights Through Worldwide Licensing Agreement
February 15, 2022

News Outlets Highlight Virpax Pharmaceuticals and Its Potential Solutions for the Opioid Crisis and COVID-19

Previous 456 Next

BUSINESS INQUIRIES

Virpax Pharmaceuticals, Inc.
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312
610.727.4597
‍info@virpaxpharma.com

MEDIA INQUIRIES

Public Relations
Virpax Pharmaceuticals, Inc.
‍pr@virpaxpharma.com

Nasdaq_Logo_wht

NASDAQ: VRPX

Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312

Phone 610.727.4597
Email info@virpaxpharma.com

Nasdaq_Logo_wht

NASDAQ: VRPX

Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312

Phone 610.727.4597
Email info@virpaxpharma.com

© Virpax^® Pharmaceuticals. All Rights Reserved.

© Virpax^® Pharmaceuticals. All Rights Reserved.

Follow @VirpaxPharma

Follow @VirpaxPharma